AIM AND SCOPE
The Journal of Antibiotics and Antimicrobial Agents aims to serve as an international platform for the publication of high-quality research, clinical studies, and scholarly contributions in the fields of antibiotics, antimicrobial therapy, and infectious disease management. The journal is dedicated to advancing scientific understanding of antimicrobial agents, including their discovery, mechanisms of action, therapeutic applications, pharmacological properties, and resistance patterns. It seeks to promote innovative and translational research that contributes to the prevention, diagnosis, and effective treatment of infectious diseases caused by bacteria, viruses, fungi, and parasites.
The journal also aims to encourage collaboration among researchers, clinicians, microbiologists, pharmacologists, and healthcare professionals worldwide for the exchange of scientific knowledge and emerging developments in antimicrobial sciences. Special emphasis is placed on antimicrobial resistance, antimicrobial stewardship, novel drug development, infection control practices, and evidence-based therapeutic strategies that improve patient care and global public health.
Scope of the journal
The Journal of Antibiotics and Antimicrobial Agents serves as an international platform for the publication of high-quality research, clinical studies, reviews, and scholarly contributions related to antibiotics, antimicrobial agents, infectious diseases, and antimicrobial therapeutics. The journal is dedicated to advancing scientific knowledge in the discovery, development, evaluation, and responsible use of antimicrobial compounds for the prevention and treatment of microbial infections.
The journal covers a broad range of topics including, but not limited to, antibiotics, antibacterial agents, antiviral agents, antifungal agents, antiparasitic agents, antimicrobial peptides, natural antimicrobial products, synthetic antimicrobial compounds, antimicrobial resistance, multidrug-resistant organisms, superbugs, hospital-acquired infections, community-acquired infections, infectious disease epidemiology, microbiology, medical microbiology, clinical microbiology, molecular microbiology, microbial genetics, bacterial pathogenesis, host-pathogen interactions, biofilms, microbial ecology, zoonotic infections, tropical infectious diseases, emerging and re-emerging infections, sepsis, immunology of infectious diseases, vaccine research, immunotherapy, pharmacology of antimicrobial agents, pharmacokinetics, pharmacodynamics, antimicrobial susceptibility testing, drug interactions, therapeutic drug monitoring, personalized antimicrobial therapy, combination therapy, antimicrobial stewardship, infection prevention and control, public health microbiology, diagnostic microbiology, molecular diagnostics, rapid diagnostic technologies, biosensors, nanotechnology in antimicrobial therapy, drug delivery systems, medicinal chemistry, biotechnology in antibiotic development, natural product chemistry, genomic and proteomic approaches in antimicrobial research, artificial intelligence in drug discovery, computational biology, bioinformatics, clinical trials, translational medicine, and global strategies to combat antimicrobial resistance.
The journal welcomes submissions related to the discovery of novel antibiotics, mechanisms of antimicrobial action and resistance, optimization of antimicrobial therapies, and innovative approaches to infection management. Studies involving laboratory research, preclinical investigations, translational research, and clinical applications are encouraged.
Types of Manuscripts
The journal accepts original research articles, review articles, systematic reviews, meta-analyses, short communications, case reports, case series, clinical studies, technical notes, perspectives, editorials, and letters to the editor.
Global Perspective and Public Health Relevance
Antimicrobial resistance is a growing global health challenge affecting healthcare systems worldwide. The journal encourages international collaboration and welcomes research addressing regional and global infectious disease burdens, antimicrobial usage patterns, surveillance programs, and public health interventions. Studies focusing on resource-limited settings, emerging pathogens, and strategies to improve access to effective antimicrobial therapy are particularly encouraged.
Ethical and Responsible Use of Antimicrobials
The journal recognizes the importance of ethical practices in antimicrobial research and clinical use. Topics related to antimicrobial stewardship, responsible prescribing practices, infection control policies, patient safety, regulatory standards, and global health policies are highly valued. Authors are expected to adhere to established ethical guidelines in research involving humans, animals, and microbial pathogens.
Education and Knowledge Dissemination
The journal is committed to promoting education and continuous professional development in the field of antibiotics and antimicrobial therapy. Educational reviews, clinical updates, and practical guidance for healthcare professionals, researchers, microbiologists, pharmacists, and students are encouraged to support evidence-based practice and scientific advancement.
Quality, Integrity, and Scientific Excellence
Maintaining scientific rigor, transparency, and integrity is a core principle of the journal. All submitted manuscripts undergo a thorough peer-review process to ensure originality, methodological quality, and scientific significance. The journal supports ethical publication practices and encourages clear, accurate, and reproducible research reporting.
Adaptability to Emerging Scientific Advances
The field of antimicrobial research continues to evolve rapidly with advances in genomics, biotechnology, precision medicine, artificial intelligence, and novel therapeutic strategies. The journal remains committed to publishing innovative and interdisciplinary research that reflects the latest developments in antimicrobial science and infectious disease management.
The Journal of Antibiotics and Antimicrobial Agents aims to contribute significantly to global scientific progress by fostering collaboration, disseminating impactful research, and supporting advancements in the prevention, diagnosis, and treatment of infectious diseases.
